MarketCap
Facebook
X
Telegram
Vivos Therapeutics Operating Cycle | VVOS
Annual Operating Cycle Vivos Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 21 | 7.67 | 8.71 | 18.9 | 28.5 | 42.3 | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 42.3 | 7.67 | 21.2 |
Quarterly Operating Cycle Vivos Therapeutics
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 25.3 | 28.1 | 17.4 | - | 10 | 10.3 | 9.7 | - | 7.67 | - | - | - | 17.8 | 19.6 | 29.1 | - | 50.5 | 29.1 | 18.2 K | - | 6.21 K | 6.01 K | 5.03 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.2 K | 7.67 | 2.23 K |
Operating Cycle of other stocks in the Medical devices industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Conformis
CFMS
|
216 | - | - | $ 16.4 M |  USA |
 |
ViewRay
VRAY
|
233 | - | 1.54 % | $ 468 M | USA |
 |
Medigus Ltd.
MDGS
|
411 | - | 10.28 % | $ 55.5 M |  Israel |
 |
Cutera
CUTR
|
462 | - | -10.19 % | $ 1.99 M | USA |
 |
Neovasc
NVCN
|
130 | - | - | $ 111 M |  Canada |
 |
Vapotherm
VAPO
|
305 | - | 6.72 % | $ 34 M | USA |
 |
Nevro Corp.
NVRO
|
359 | - | - | $ 217 M | USA |
 |
Venus Concept
VERO
|
542 | - | - | $ 726 K | USA |
 |
Eargo
EAR
|
156 | - | - | $ 10.2 M | USA |
 |
Sientra
SIEN
|
866 | - | -16.59 % | $ 10.3 M | USA |
 |
Silk Road Medical, Inc
SILK
|
222 | - | - | $ 1.07 B | USA |
 |
Surgalign Holdings
SRGA
|
271 | - | -32.98 % | $ 1.68 M | USA |
 |
Cardiovascular Systems
CSII
|
254 | - | 0.15 % | $ 844 M | USA |
 |
ShockWave Medical
SWAV
|
396 | - | - | $ 12.3 B | USA |
 |
Inari Medical
NARI
|
281 | - | - | $ 4.23 B | USA |
 |
Zynex
ZYXI
|
168 | - | - | $ 21.1 M | USA |
 |
Abiomed
ABMD
|
112 | - | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
294 | - | 3.58 % | $ 2.21 M | USA |
 |
Natus Medical Incorporated
NTUS
|
79 | - | 1.94 % | $ 1.05 B | USA |
 |
Nemaura Medical
NMRD
|
7.86 K | - | -17.8 % | $ 2.74 M |  Britain |
 |
Butterfly Network
BFLY
|
554 | $ 6.36 | 5.12 % | $ 1.57 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
321 | - | - | $ 3.31 B | USA |
 |
Sensus Healthcare
SRTS
|
459 | $ 2.88 | -1.54 % | $ 47 M | USA |
 |
Sintx Technologies
SINT
|
502 | $ 1.56 | -3.7 % | $ 4.33 M | USA |
 |
Invacare Corporation
IVC
|
289 | - | - | $ 24.7 M | USA |
 |
Quanterix Corporation
QTRX
|
298 | $ 2.92 | 5.8 % | $ 125 M | USA |
 |
Boston Scientific Corporation
BSX
|
169 | $ 42.83 | -4.03 % | $ 63.4 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
159 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
128 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
194 | - | -5.86 % | $ 30.6 M | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 5.47 | 3.01 % | $ 3.69 M | USA |
 |
Apyx Medical Corporation
APYX
|
260 | $ 2.93 | -4.25 % | $ 120 M | USA |
 |
Establishment Labs Holdings
ESTA
|
586 | $ 67.14 | 4.22 % | $ 1.99 B |  Costa-rica |
 |
Delcath Systems
DCTH
|
314 | $ 14.95 | 3.17 % | $ 536 M | USA |
 |
Electromed
ELMD
|
215 | $ 26.94 | 1.4 % | $ 223 M | USA |
 |
Inogen
INGN
|
83.5 | $ 6.01 | -11.23 % | $ 160 M | USA |
 |
Globus Medical
GMED
|
347 | $ 70.75 | -13.21 % | $ 9.57 B | USA |
 |
IRadimed Corporation
IRMD
|
259 | $ 85.54 | -0.33 % | $ 1.09 B | USA |
 |
ClearPoint Neuro
CLPT
|
250 | $ 8.62 | -0.81 % | $ 244 M | USA |
 |
Accuray Incorporated
ARAY
|
249 | $ 0.11 | -11.22 % | $ 13.5 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
AxoGen
AXGN
|
279 | $ 49.95 | 2.46 % | $ 2.3 B | USA |
 |
IRIDEX Corporation
IRIX
|
69.4 | $ 0.68 | -0.63 % | $ 11.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
212 | $ 4.81 | 4.56 % | $ 299 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
271 | $ 13.43 | -4.89 % | $ 1.03 B | USA |
 |
Bruker Corporation
BRKR
|
271 | $ 61.34 | 5.7 % | $ 9.31 B | USA |
 |
LivaNova PLC
LIVN
|
181 | $ 90.02 | -1.23 % | $ 4.91 B | Britain |
 |
Profound Medical Corp.
PROF
|
706 | $ 7.22 | 4.94 % | $ 218 M | Canada |
 |
LENSAR
LNSR
|
231 | $ 5.44 | -1.09 % | $ 65.1 M | USA |